Prevent Blindness announces its fourth annual Geographic Atrophy Awareness Week, December 2 to 8, 2024. The organization ...

Findings from a post hoc analysis of the AREDS and AREDS2 studies were presented at the recent American Academy of ...

Post hoc analyses of the AREDS / AREDS2 studies presented at the recent American Academy of Ophthalmology meeting examined supplementation on the risk of geographic atrophy progression.

Early diagnosis of rare diseases like Spinal Muscular Atrophy (SMA) is crucial for managing symptoms and improving quality of ...

Luis's wheelchair is part of his everyday life with spinal muscular atrophy and he faces challenges with mobility and living ...

Despite disappointing results in the genetic neurodegenerative disorder, the drug shows potential for treating obesity.

By Mariam Sunny (Reuters) -Biohaven said on Monday its experimental treatment for a rare neuromuscular disorder failed to ...

Lundbeck initiates a phase III trial with amlenetug for the treatment of Multiple System AtrophyMASCOT, a global phase III randomized, double-blind, placebo-controlled trial, will assess the efficacy ...

Prevent Blindness, the nation's leading nonprofit eye health organization, is announcing Dec. 2-8, 2024, as its fourth annual Geographic Atrophy (GA) Awareness Week. GA is an advanced form of dry ...

One major health challenge in the aging population is the decline in muscle mass, strength and function (otherwise known as ...

The New Haven, Conn., biopharmaceutical company said Monday that taldefgrobep had shown clinically meaningful improvements in motor function in spinal muscular atrophy patients, but the treatment arm ...

The authors emphasize the value of subgroup analyses for tracking patterns in spinal muscular atrophy (SMA), as opposed to ...